{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:53:53Z","timestamp":1778241233756,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jdermsci.2020.05.010","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T17:42:47Z","timestamp":1590946967000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Genetic predisposition to bullous pemphigoid"],"prefix":"10.1016","volume":"100","author":[{"given":"Jieyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9863","key":"10.1016\/j.jdermsci.2020.05.010_bib0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2020.05.010_bib0010","series-title":"Global incidence and prevalence of bullous pemphigoid: a systematic review and meta-analysis","author":"Lu","year":"2020"},{"key":"10.1016\/j.jdermsci.2020.05.010_bib0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"issue":"2","key":"10.1016\/j.jdermsci.2020.05.010_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/jamadermatol.2018.4390","article-title":"Assessment of diagnostic strategy for early recognition of bullous and nonbullous variants of pemphigoid","volume":"155","author":"Meijer","year":"2019","journal-title":"JAMA Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.010_bib0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archdermatol.2011.21","article-title":"Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid","volume":"147","author":"Roussel","year":"2011","journal-title":"Arch. Dermatol."},{"issue":"4\u20135","key":"10.1016\/j.jdermsci.2020.05.010_bib0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.jdermsci.2020.05.010_bib0035","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.4049\/jimmunol.1003402","article-title":"Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner","volume":"188","author":"Natsuga","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2020.05.010_bib0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clindermatol.2013.01.006","article-title":"Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies","volume":"31","author":"Lo Schiavo","year":"2013","journal-title":"Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2020.05.010_bib0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.smim.2011.01.015","article-title":"Genetic predisposition to autoimmunity--what have we learned?","volume":"23","author":"Rai","year":"2011","journal-title":"Semin. Immunol."},{"issue":"5","key":"10.1016\/j.jdermsci.2020.05.010_bib0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri.2017.143","article-title":"HLA variation and disease","volume":"18","author":"Dendrou","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2020.05.010_bib0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1399-0039.1987.tb01620.x","article-title":"Probable association between HLA-DR5 and bullous pemphigoid","volume":"30","author":"Seignalet","year":"1987","journal-title":"Tissue Antigens"},{"issue":"16","key":"10.1016\/j.jdermsci.2020.05.010_bib0060","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jdermsci.2020.05.010_bib0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autrev.2011.07.002","article-title":"Role of MHC Class II genes in the pathogenesis of pemphigoid","volume":"11","author":"Zakka","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.jdermsci.2020.05.010_bib0070","first-page":"1","article-title":"Association between HLA-DQB1*03:01 and bullous pemphigoid in Iranian patients","volume":"10","author":"Esmaili","year":"2013","journal-title":"Iran. J. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.010_bib0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jdermsci.2017.11.014","article-title":"Association of HLA class I and class II alleles with bullous pemphigoid in Chinese Hans","volume":"89","author":"Fang","year":"2018","journal-title":"J. Dermatol. Sci."},{"issue":"8","key":"10.1016\/j.jdermsci.2020.05.010_bib0080","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jid.2018.02.021","article-title":"The HLA-DQB1*03:01 is associated with bullous pemphigoid in the Han Chinese population","volume":"138","author":"Sun","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2020.05.010_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5021\/ad.2018.30.1.8","article-title":"HLA-C*17, DQB1*03:01, DQA1*01:03 and DQA1*05:05 alleles associated to bullous pemphigoid in Brazilian population","volume":"30","author":"Chagury","year":"2018","journal-title":"Ann. Dermatol."},{"issue":"12","key":"10.1016\/j.jdermsci.2020.05.010_bib0090","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"Budinger","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.jdermsci.2020.05.010_bib0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2249.2010.04239.x","article-title":"Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously","volume":"162","author":"Zakka","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.010_bib0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2133.2001.04380.x","article-title":"Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production","volume":"145","author":"Setterfield","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2020.05.010_bib0105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ijc.2910590413","article-title":"HLA-DQB1*0301 association with increased cutaneous melanoma risk","volume":"59","author":"Lee","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jdermsci.2020.05.010_bib0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biopha.2015.06.002","article-title":"The HLA-DQB1 gene polymorphisms associated with cervical cancer risk: a meta-analysis","volume":"73","author":"Zhang","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.jdermsci.2020.05.010_bib0115","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc19-0409","article-title":"Dipeptidyl peptidase 4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes","volume":"42","author":"Douros","year":"2019","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jdermsci.2020.05.010_bib0120","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jid.2017.11.023","article-title":"HLA-DQB1*03:01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors","volume":"138","author":"Ujiie","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2020.05.010_bib0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1684\/ejd.2017.3066","article-title":"The association between bullous pemphigoid and neurological disorders: a systematic review","volume":"27","author":"Milani-Nejad","year":"2017","journal-title":"Eur. J. Dermatol."},{"issue":"10","key":"10.1016\/j.jdermsci.2020.05.010_bib0130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ng.3395","article-title":"Class II HLA interactions modulate genetic risk for multiple sclerosis","volume":"47","author":"Moutsianas","year":"2015","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.010_bib0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/iji.12266","article-title":"Susceptible and protective associations of HLA DRB1*\/DQB1* alleles and haplotypes with ischaemic stroke","volume":"43","author":"Murali","year":"2016","journal-title":"Int. J. Immunogenet."},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.010_bib0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/tan.12960","article-title":"A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?","volume":"89","author":"Amber","year":"2017","journal-title":"HLA"},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.010_bib0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1346-8138.2000.tb02141.x","article-title":"Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid","volume":"27","author":"Okazaki","year":"2000","journal-title":"J. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2020.05.010_bib0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2230.2002.01037.x","article-title":"HLA-DR and DQ polymorphisms in bullous pemphigoid from northern China","volume":"27","author":"Gao","year":"2002","journal-title":"Clin. Exp. Dermatol."},{"issue":"7653","key":"10.1016\/j.jdermsci.2020.05.010_bib0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature22329","article-title":"Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells","volume":"545","author":"Ooi","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jdermsci.2020.05.010_bib0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/molehr\/gal100","article-title":"Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells","volume":"13","author":"van der Meer","year":"2007","journal-title":"Mol. Hum. Reprod."},{"issue":"6","key":"10.1016\/j.jdermsci.2020.05.010_bib0165","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1365-2133.2000.03901.x","article-title":"Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay","volume":"143","author":"Eming","year":"2000","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.010_bib0170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/ced.13371","article-title":"Increased sensitivity and high specificity of indirect immunofluorescence in detecting IgG subclasses for diagnosis of bullous pemphigoid","volume":"43","author":"Jankaskova","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2020.05.010_bib0175","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.177.5.3398","article-title":"Role of FcRs in animal model of autoimmune bullous pemphigoid","volume":"177","author":"Zhao","year":"2006","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.jdermsci.2020.05.010_bib0180","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/jid.2010.230","article-title":"FcgammaRIIA and FcgammaRIIIB are required for autoantibody-induced tissue damage in experimental human models of bullous pemphigoid","volume":"130","author":"Yu","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2020.05.010_bib0185","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jaut.2015.05.004","article-title":"Allelic and copy-number variations of FcgammaRs affect granulocyte function and susceptibility for autoimmune blistering diseases","volume":"61","author":"Recke","year":"2015","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.010_bib0190","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.0906-6705.2004.0138.x","article-title":"Genetic variation in COL17A1 and the development of bullous pemphigoid","volume":"13","author":"Winsey","year":"2004","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2020.05.010_bib0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Bagci","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jdermsci.2020.05.010_bib0200","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2019.00636","article-title":"Proinflammatory cytokine gene polymorphisms in bullous pemphigoid","volume":"10","author":"Tabatabaei-Panah","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jdermsci.2020.05.010_bib0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.jdermsci.2020.05.010_bib0210","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","article-title":"Mitochondria: in sickness and in health","volume":"148","author":"Nunnari","year":"2012","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jdermsci.2020.05.010_bib0215","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/exd.12732","article-title":"Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population","volume":"24","author":"Hirose","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"24","key":"10.1016\/j.jdermsci.2020.05.010_bib0220","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1093\/hmg\/ddp432","article-title":"The mtDNA nt7778 G\/T polymorphism affects autoimmune diseases and reproductive performance in the mouse","volume":"18","author":"Yu","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jdermsci.2020.05.010_bib0225","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3389\/fimmu.2019.02200","article-title":"Polymorphisms in the mitochondrial genome are associated with bullous pemphigoid in germans","volume":"10","author":"Russlies","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jdermsci.2020.05.010_bib0230","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nri.2017.66","article-title":"Mitochondrial control of immunity: beyond ATP","volume":"17","author":"Mehta","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jdermsci.2020.05.010_bib0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/DMR-120001389","article-title":"Drugs as P-glycoprotein substrates, inhibitors, and inducers","volume":"34","author":"Kim","year":"2002","journal-title":"Drug Metab. Rev."},{"issue":"5","key":"10.1016\/j.jdermsci.2020.05.010_bib0240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/ddg.13182","article-title":"ABCB1 gene is associated with the risk of bullous pemphigoid in a polish population","volume":"15","author":"Rychlik-Sych","year":"2017","journal-title":"J. Dermatol. Ges."},{"issue":"6","key":"10.1016\/j.jdermsci.2020.05.010_bib0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00403-018-1842-8","article-title":"Haplotypes of ABCB1 1236C &T (rs1128503), 2677G &T\/A (rs2032582), and 3435C &T (rs1045642) in patients with bullous pemphigoid","volume":"310","author":"Rychlik-Sych","year":"2018","journal-title":"Arch. Dermatol. Res."},{"issue":"12","key":"10.1016\/j.jdermsci.2020.05.010_bib0250","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/ijd.12967","article-title":"The impact of the CYP2D6 gene polymorphism on the risk of pemphigoid","volume":"54","author":"Rychlik-Sych","year":"2015","journal-title":"Int. J. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092318112030178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092318112030178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:51:24Z","timestamp":1760331084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092318112030178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S092318112030178X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2020.05.010","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predisposition to bullous pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2020.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}